| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 6232-49-1 | 媒介黃26; 5,5'-[(2,2'-二磺酸[1,1'-聯(lián)苯]-4,4'-二基)雙(偶氮)]二水楊酸四鈉鹽 | Mordant Yellow 26; Acid mordant Yellow 26; Tetrasodium 5,5'-[(2,2'-disulphonato[1,1'-biphenyl]-4,4'-diyl)bis(azo)]disalicylate |  | C26H14N4Na4O12S2 | 詳情 | 供應(yīng)商 |
| 27025-41-8 | L-谷胱甘肽(氧化型) | L(-)-Glutathione; Glutathione disulfide |  | C20H32N6O12S2 | 詳情 | 供應(yīng)商 |
| 83105-70-8 | 對(duì)甲苯磺酸舒他西林; (2S,5R)-3,3-二甲基-4,4-二氧化-7-氧代-4-硫雜-1-氮雜雙環(huán)[3.2.0]正庚烷-2-羰基氧甲基( | Sultamicillin tosilate; [[[(2S,5R)-3,3-Dimethyl-4,4-dioxido-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]oxy]methyl (2S,5R,6R)-6-[[(2R)-Aminophenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-ca |  | C25H30N4O9S2.C7H8O3S;C32H38N4O12S3 | 詳情 | 供應(yīng)商 |
| 147098-20-2 | 瑞舒伐他汀鈣; 羅舒伐他汀鈣; 超級(jí)他汀鈣; (3R,5S,6E)-7-[4-(4-氟苯基)-6-異丙基-2-(N-甲基-N-甲磺酰胺基)-5-? | Rosuvastatin calcium; 7-{4-(4-Fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid |  | 2(C22H27FN3O6S).Ca;C44H54CaF2N6O12S2 | 詳情 | 供應(yīng)商 |
| 7451-57-2 | 2,2'-[(1,8-二羥基-3,6-二磺基-2,7-萘二基)雙(偶氮)]二苯甲酸; 偶氮羧III; 2,2'-(1,8-二羥基萘-3,6-二磺鈉-2, | 2,2'-[(1,8-dihydroxy-3,6-disulfo-2,7-naphthalenediyl)bis(azo)]bis-Benzoic acid; Carboxyazo III |  | C24H16N4O12S2 | 詳情 | 供應(yīng)商 |
| 74186-17-7 | 2-羥基-5-[[5-甲基-4-[(4-硝基-2-磺基苯基)偶氮]-2-(3-磺丙氧基)苯基]偶氮]苯甲酸三鈉鹽 | Benzoic acid, 2-hydroxy-5-[[5-methyl-4-[(4-nitro-2-sulfophenyl)azo]-2-(3-sulfopropoxy)phenyl]azo]-, |  | C23H21N5O12S2 | 詳情 | 供應(yīng)商 |
| 90066-12-9 | 4-[3-[3-羧基-5-羥基-1-(4-磺苯基)-1H-吡唑-4-基]-2-亞丙烯基]-4,5-二氫-5-氧代-1-(4-磺苯基)-1H-吡唑-3-甲 | 1H-Pyrazole-3-carboxylic acid, 4-[3-[3-carboxy-5-hydroxy-1-(4-sulfophenyl)-1H-pyrazol-4-yl]-2-propen; 4-[3-[3-Carboxy-5-hydroxy-1-(4-sulfophenyl)-1H-pyrazol-4-yl]-2-propenylidene]-4,5-dihydro-5-oxo-1-(4-sulfophenyl)-1Hpyrazole-3-carboxylic acid, sodium and triethylamine salts |  | C23H16N4O12S2.xC6H15N.xNa | 詳情 | 供應(yīng)商 |
| 66096-14-8 | 4-[3-[3-羧基-5-羥基-1-(4-磺苯基)-1H-吡唑-4-基]-2-亞丙烯基]-4,5-二氫-5-氧代-1-(4-磺苯基)-1-吡唑-3-羧? | 1H-Pyrazole-3-carboxylic acid, 4-[3-[3-carboxy-5-hydroxy-1-(4-sulfophenyl)-1H-pyrazol-4-yl]-2-propen; 1H-Pyrazole-3-carboxylic acid, 4-[3-[3-carboxy-5-hydroxy-1-(4-sulfophenyl)-1H-pyrazol-4-yl]allylidene]-4,5-dihydro-5-oxo-1-(4-sulfophenyl)-, dipotassium salt; 1H-Pyrazole-3-carboxylic acid,4-[3-[3-carboxy-5-hydroxy-1-(4-sulfophenyl)-1H-pyrazol-4-yl]-2-propenylidene]-4,5-dihydro-5-oxo-1-(4-sulfophenyl)-,dipotassium salt; 1H-Pyrazole-3-carboxylic acid,4-[3-[3-carboxy-5-hydroxy-1-(4-sulfophenyl)-1H-pyrazol-4-yl]allylidene]-4,5-dihydro-5-oxo-1-(4-sulfophenyl)-,dipotassium salt |  | C23H16N4O12S2.2K | 詳情 | 供應(yīng)商 |
| 6492-53-1 | Benzoic acid,3,3'-[1,4-phenylenebis(2,1-diazenediyl)]bis[6-hydroxy-5-sulfo-, sodium salt(1:4); Benzoicacid, 3,3'-[1,4-phenylenebis(azo)]bis[6-hydroxy-5-sulfo-, tetrasodium salt(9CI); C.I. Mordant Orange 22, tetrasodium salt (8CI); C.I. 21570; ChromazolOrange R; Chrome Fast Yellow 2R |  | C20H10N4Na4O12S2 | 詳情 | 供應(yīng)商 | |
| 68921-90-4 | Ethanesulfonic acid,2-[[(2R)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl]amino]-, calcium salt (1:?); Ethanesulfonicacid, 2-[(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)amino]-, calcium salt, (R)-; Ethanesulfonic acid, 2-[[(2R)-2,4-dihydroxy-3,3-dimethyl-1-oxobutyl]amino]-,calcium salt (9CI) |  | C16H32CaN2O12S2 | 詳情 | 供應(yīng)商 | |
| 103239-24-3 | 谷胱甘肽(氧化型)二鈉鹽; 谷胱甘肽(氧化型)二鈉鹽; 氧化谷胱甘肽二鈉鹽 | Glycine, L-g-glutamyl-L-cysteinyl-, bimol. (2®2')-disulfide, sodium salt (1:2); Glycine,L-g-glutamyl-L-cysteinyl-, (2® 2')-disulfide, disodium salt; Glycine,L-g-glutamyl-L-cysteinyl-, bimol. (2® 2')-disulfide, disodium salt(9CI); Gluthoxim; Glutoxim; NOV 002 |  | C20H32N6O12S2.2Na | 詳情 | 供應(yīng)商 |
| 23067-16-5 | L-Cystine,N,N'-bis(2,4-dinitrophenyl)-; Cystine,N,N'-bis(2,4-dinitrophenyl)- (6CI); Cystine, N,N'-bis(2,4-dinitrophenyl)-, L-(8CI); N,N'-Bis(2,4-dinitrophenyl)cystine (7CI); Di-2,4-dinitrophenyl-L-cystine; Di-DNP-cystine; N,N-Di(DNP)-L-cystine; N,N'-Bis(2,4-dinitrophenyl)-L-cystine; NSC 505719 |  | C18H16N6O12S2 | 詳情 | 供應(yīng)商 | |
| 81998-39-2 | Platinate(6-), bis[L-g-glutamyl-L-cysteinyl-kN,kS-glycinato(4-)]-, hexahydrogen, (SP-4-1)- (9CI); Platinate(6-),bis[N-(N-L-g-glutamyl-L-cysteinyl)glycinato(4-)]-,hexahydrogen, (SP-4-1)-; Glycine, N-(N-L-g-glutamyl-L-cysteinyl)-, platinum complex |  | C20H26N6O12PtS2.6H | 詳情 | 供應(yīng)商 | |
| 29844-04-0 | 1,6-Naphthalenedisulfonicacid, 8-hydroxy-7-[2-(2-hydroxy-3,5-dinitrophenyl)diazenyl]-; 1,6-Naphthalenedisulfonicacid, 8-hydroxy-7-[(2-hydroxy-3,5-dinitrophenyl)azo]- (8CI,9CI); Picramine E; Picramine-e |  | C16H10N4O12S2 | 詳情 | 供應(yīng)商 | |
| 133906-27-1 | 2,4(1H,3H)-Pyrimidinedione,1-(2-amino-2-deoxy-4,6-di-O-sulfo-b-D-glucopyranosyl)-5-methyl-; 1-thyminylglucosamine-4,6-disulfate |  | C11H17N3O12S2 | 詳情 | 供應(yīng)商 | |
| 6388-42-7 | 2,6-Anthracenedisulfonicacid, 4,8-diamino-9,10-dihydro-1,3,5,7-tetrahydroxy-9,10-dioxo-; 2,6-Anthrachrysonedisulfonicacid, 4,8-diamino- |  | C14H10N2O12S2 | 詳情 | 供應(yīng)商 | |
| 27991-09-9 | 2,7-Naphthalenedisulfonicacid, 4-hydroxy-3-[2-(2-hydroxy-3,5-dinitrophenyl)diazenyl]-; 2,7-Naphthalenedisulfonicacid, 4-hydroxy-3-[(2-hydroxy-3,5-dinitrophenyl)azo]- (8CI,9CI); Picramine RG |  | C16H10N4O12S2 | 詳情 | 供應(yīng)商 | |
| 192575-19-2 | PPADS TETRASODIUM SALT; PYRIDOXALPHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID TETRASODIUM SALT; PYRIDOXALPHOSPHATE-6-AZOPHENYL-2',4'-DISULPHONIC ACID 4NA; PYRIDOXAL-PHOSPHATE-6-AZOPHENYL-2',4'-DISULPHONIC ACID TETRASODIUM; PPADS; PPADS TETRASODIUM SALT; 4-[[4-FORMYL-5-HYDROXY-6-METHYL-3-[(PHOSPHONOOXY)METHYL]-2-PYRIDINYL]AZO]-1,3-BENZENEDISULFONIC ACID TETRASODIUM; pyridoxal-phosphate-6-azophenyl-2',4'- disulfoni; PYRIDOXAL-PHOSPHATE-6-AZOPHENYL-2',4'-DI -SULPHONIC ACID TETRAS |  | C14H10N3Na4O12PS2 | 詳情 | 供應(yīng)商 | |
| 68893-82-3 | 甲狀旁腺激素 人類 | Parathyroid hormone human |  | C408H674N126O126S2 | 詳情 | 供應(yīng)商 |
| 163706-06-7 | 坎格雷洛 | Cangrelor | 無(wú) | C17H25Cl2F3N5O12P3S2 | 詳情 | 供應(yīng)商 |